Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Matthew McMaster, Kelly Mohr, Austin Page, Adam Closmore, Francina Towne & Benjamin D. Brooks. (2021) Epitope characterization of anti-drug antibodies—a tool for discovery and health: an overview of the necessity of early epitope characterization to avoid anti-drug antibodies and promote patient health. Expert Opinion on Biological Therapy 21:6, pages 705-715.
Read now
Read now
Oliver von Richter, Lena Lemke, Halimuniyazi Haliduola, Alison Balfour, Britta Zehnpfennig, Andrej Skerjanec & Julia Jauch-Lembach. (2019) Differences in immunogenicity associated with non-product related variability: insights from two pharmacokinetic studies using GP2017, an adalimumab biosimilar. Expert Opinion on Biological Therapy 19:10, pages 1057-1064.
Read now
Read now
Articles from other publishers (12)
Anna Davydova, Yuliya Kurochkina, Veronika Goncharova, Mariya Vorobyeva & Maksim Korolev. (2023) The Interleukine-17 Cytokine Family: Role in Development and Progression of Spondyloarthritis, Current and Potential Therapeutic Inhibitors. Biomedicines 11:5, pages 1328.
Crossref
Crossref
Jill L. Kinzer, Troy A. Halseth, Jukyung Kang, Sang Yeop Kim, Preethi Kumaran, Michael Ford, Sergei Saveliev, St John Skilton & Anna Schwendeman. (2023) Physicochemical characterization and functionality comparison of Humira®(adalimumab), Remicade®(infliximab) and Simponi Aria® (golimumab). International Journal of Pharmaceutics 635, pages 122646.
Crossref
Crossref
Annmaree K. Warrender, Jolyn Pan, Chris R. Pudney, Vickery L. Arcus & William Kelton. (2023) Constant domain polymorphisms influence monoclonal antibody stability and dynamics. Protein Science 32:3.
Crossref
Crossref
Teresa Tsakok, Jake Saklatvala, Theo Rispens, Floris C. Loeff, Annick de Vries, Michael H. Allen, Ines A. Barbosa, David Baudry, Tejus Dasandi, Michael Duckworth, Freya Meynell, Alice Russell, Anna Chapman, Sandy McBride, Kevin McKenna, Gayathri Perera, Helen Ramsay, Raakhee Ramesh, Kathleen Sands, Alexa Shipman, A. David Burden, Christopher E.M. Griffiths, Nick J. Reynolds, Richard B. Warren, Satveer Mahil, Jonathan Barker, Nick Dand, Catherine Smith & Michael A. Simpson. (2023) Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove. JCI Insight 8:4.
Crossref
Crossref
Michel Siegel, Guido Steiner, Linnea C. Franssen, Francesca Carratu, James Herron, Katharina Hartman, Cary M. Looney, Axel Ducret, Katharine Bray-French, Olivier Rohr, Timothy P. Hickling, Noel Smith & Céline Marban-Doran. (2022) Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics. Pharmaceutics 14:12, pages 2672.
Crossref
Crossref
Romy Mosch & Henk-Jan Guchelaar. (2022) Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients. Frontiers in Immunology 13.
Crossref
Crossref
Christian Hammer, Jane Ruppel, Lynn Kamen, Julie Hunkapiller, Ira Mellman & Valerie Quarmby. (2022)
Allelic variation in
HLA‐DRB1
is associated with development of a
ntidrug
antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro
. Clinical and Translational Science 15:6, pages 1393-1399.
Crossref
Crossref
Miguel Borregón, Katherine Martínez, Alba Ramos, Irene Ramos, Beatriz Berzal, Manuel Mazariegos, Elia Martínez, Tatiana Hernández, Bernard Doger & Víctor Moreno. (2022) Anti-drug antibodies in the current management of cancer. Cancer Chemotherapy and Pharmacology 89:5, pages 577-584.
Crossref
Crossref
Rotondo-Trivette S & Michail S. (2021) Pediatric Inflammatory Bowel Disease. Asploro Journal of Pediatrics and Child Health 3:1, pages 11-17.
Crossref
Crossref
Anna Vaisman-Mentesh, Matias Gutierrez-Gonzalez, Brandon J. DeKosky & Yariv Wine. (2020) The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies. Frontiers in Immunology 11.
Crossref
Crossref
Vibha Jawa, Frances Terry, Jochem Gokemeijer, Shibani Mitra-Kaushik, Brian J. Roberts, Sophie Tourdot & Anne S. De Groot. (2020) T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020. Frontiers in Immunology 11.
Crossref
Crossref
Sadaf Atiqi, Femke Hooijberg, Floris C. Loeff, Theo Rispens & Gerrit J. Wolbink. (2020) Immunogenicity of TNF-Inhibitors. Frontiers in Immunology 11.
Crossref
Crossref